These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 6708928)

  • 1. The kinetics of competitive radioligand binding predicted by the law of mass action.
    Motulsky HJ; Mahan LC
    Mol Pharmacol; 1984 Jan; 25(1):1-9. PubMed ID: 6708928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical method for simultaneously measuring ex vivo drug receptor occupancy and dissociation rate: application to (R)-dimethindene occupancy of central histamine H1 receptors.
    Malany S; Hernandez LM; Smith WF; Crowe PD; Hoare SR
    J Recept Signal Transduct Res; 2009; 29(2):84-93. PubMed ID: 19308787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kinetic and equilibrium studies of Ah receptor-ligand binding: use of [125I]2-iodo-7,8-dibromodibenzo-p-dioxin.
    Bradfield CA; Kende AS; Poland A
    Mol Pharmacol; 1988 Aug; 34(2):229-37. PubMed ID: 2842655
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of Kinetic Binding Properties of Unlabeled Ligands via a Preincubation Endpoint Binding Approach.
    Shimizu Y; Ogawa K; Nakayama M
    J Biomol Screen; 2016 Aug; 21(7):729-37. PubMed ID: 27270099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ligand dissociation constants from competition binding assays: errors associated with ligand depletion.
    Goldstein A; Barrett RW
    Mol Pharmacol; 1987 Jun; 31(6):603-9. PubMed ID: 3600604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of cooperativity on the determination of dissociation constants: examination of the Cheng-Prusoff equation, the Scatchard analysis, the Schild analysis and related power equations.
    Cheng HC
    Pharmacol Res; 2004 Jul; 50(1):21-40. PubMed ID: 15082026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pharmacological basis of receptor binding.
    Schütz W
    Wien Klin Wochenschr; 1991; 103(15):438-42. PubMed ID: 1656614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro receptor binding assays: general methods and considerations.
    Bigott-Hennkens HM; Dannoon S; Lewis MR; Jurisson SS
    Q J Nucl Med Mol Imaging; 2008 Sep; 52(3):245-53. PubMed ID: 18475249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods.
    Ehlert FJ
    Mol Pharmacol; 1988 Feb; 33(2):187-94. PubMed ID: 2828914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scintillation proximity assay as a high-throughput method to identify slowly dissociating nonpeptide ligand binding to the GnRH receptor.
    Heise CE; Sullivan SK; Crowe PD
    J Biomol Screen; 2007 Mar; 12(2):235-9. PubMed ID: 17208923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Competitive association binding kinetic assays: a new tool to detect two different binding orientations of a ligand to its target protein under distinct conditions?
    Wittmann HJ; Strasser A
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Jun; 390(6):595-612. PubMed ID: 28220211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reinterpreting anomalous competitive binding experiments within G protein-coupled receptor homodimers using a dimer receptor model.
    Casadó-Anguera V; Moreno E; Mallol J; Ferré S; Canela EI; Cortés A; Casadó V
    Pharmacol Res; 2019 Jan; 139():337-347. PubMed ID: 30472462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GPCR-radioligand binding assays.
    Flanagan CA
    Methods Cell Biol; 2016; 132():191-215. PubMed ID: 26928545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radioligand binding assays and their analysis.
    Maguire JJ; Kuc RE; Davenport AP
    Methods Mol Biol; 2012; 897():31-77. PubMed ID: 22674160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimation of ligand binding parameters by simultaneous fitting of association and dissociation data: a Monte Carlo simulation study.
    Karlsson MO; Neil A
    Mol Pharmacol; 1989 Jan; 35(1):59-66. PubMed ID: 2913484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding kinetics redefine the antagonist pharmacology of the corticotropin-releasing factor type 1 receptor.
    Fleck BA; Hoare SR; Pick RR; Bradbury MJ; Grigoriadis DE
    J Pharmacol Exp Ther; 2012 May; 341(2):518-31. PubMed ID: 22357972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies on kinetics of [3H]beta-funaltrexamine binding to mu opioid receptor.
    Liu-Chen LY; Li SX; Tallarida RJ
    Mol Pharmacol; 1990 Feb; 37(2):243-50. PubMed ID: 2154672
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancer and competitive allosteric modulation model for G-protein-coupled receptors.
    Pietra D; Borghini A; Breschi MC; Bianucci AM
    J Theor Biol; 2010 Dec; 267(4):663-75. PubMed ID: 20800599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of antipsychotic drugs on dopamine-receptors on caudate calf].
    Guo QY
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Oct; 25(5):296-9, 317-8. PubMed ID: 1363315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Radioligand exchange binding cannot directly determine the dissociation constant (Kd) of the rat ventral prostate nuclear androgen receptor: valid Kd determinations require additional uptake binding data.
    Chapman JC; Freeh SM; Michael SD
    Arch Biochem Biophys; 1993 Dec; 307(2):242-7. PubMed ID: 8274009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.